PELTHOS THERAPEUTICS INC (PTHS) Institutional Shareholders

PELTHOS THERAPEUTICS INC (PTHS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $37.39M in PTHS holdings during the latest filing period.

Aigh Capital Management Llc is currently the largest disclosed institutional shareholder of PTHS tracked by InsiderSet, reporting ownership valued at approximately $9.30M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $7.45M, representing an estimated loss of -19.85% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 93% of the total disclosed PTHS value among the investors covered in this analysis. Major shareholders include Aigh Capital Management Llc, Murchinson Ltd., Ikarian Capital, Llc, and several other long-term asset managers with concentrated positions in PELTHOS THERAPEUTICS INC (PTHS).

This page ranks the largest institutional PTHS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

23

Total Reported Value

$37.39M

Largest Holder

Aigh Capital Management Llc

Largest Position

$9.30M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

29

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Aigh Capital Management Llc0.84%329,098$9,300,309$7,454,070-$1,846,239-19.85%
Murchinson Ltd.4.15%304,302$8,599,575$6,892,440-$1,707,135-19.85%
Ikarian Capital, Llc1.19%256,598$7,251,459$5,811,945-$1,439,514-19.85%
Boothbay Fund Management, Llc0.05%101,976$2,881,842$2,309,756-$572,086-19.85%
Vanguard Capital Management Llc0.00%97,134$2,745,007$2,200,085-$544,922-19.85%
Cantor Fitzgerald, L. P.0.02%38,123$1,077,356$863,486-$213,870-19.85%
J. Goldman & Co Lp0.04%38,075$1,076,000$862,399-$213,601-19.85%
Diadema Partners Lp0.25%24,773$700,085$561,108-$138,977-19.85%
Wexford Capital Lp0.09%22,364$632,007$506,545-$125,462-19.85%
Knott David M Jr0.33%22,073$623,783$499,953-$123,830-19.85%
Citadel Advisors Llc0.00%15,046$425,200$340,792-$84,408-19.85%
Geode Capital Management, Llc0.00%14,650$414,008$331,823-$82,186-19.85%
Pale Fire Capital Se0.03%12,919$365,091$292,615-$72,476-19.85%
1492 Capital Management Llc0.09%10,380$293,339$235,107-$58,232-19.85%
Vanguard Fiduciary Trust Co0.00%9,873$279,011$223,623-$55,388-19.85%
State Street Corp0.00%9,800$276,948$221,970-$54,978-19.85%
Persistent Asset Partners Ltd0.05%6,007$169,758$136,059-$33,699-19.85%
Blackrock, Inc.0.00%5,324$150,457$120,589-$29,868-19.85%
Ubs Group Ag0.00%2,217$62,652$50,215-$12,437-19.85%
China Universal Asset Management Co., Ltd.0.00%2,160$61,042$48,924-$12,118-19.85%
Tower Research Capital Llc (Trc)0.00%205$5,793$4,643-$1,150-19.85%
Farther Finance Advisors, Llc0.00%40$1,130$906-$224-19.82%
Barclays Plc0.00%20$565$453-$112-19.82%
Showing 23 of 23

Frequently asked questions about PTHS

  • Who owns the most PTHS stock?

    The largest holders of PTHS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PELTHOS THERAPEUTICS INC (PTHS).

  • Is PTHS widely held by superinvestors?

    Many widely followed stocks like PTHS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PTHS is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.